Published January 1, 2017
| Version v1
Journal article
Open
Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A
Description
Background: The number of cancer cases around the world has increased according to the World Health Organization (WHO) reports, nearly 14 million new cases and 8.2 million cancer associated mortalities have been reported in 2012. Chemotherapeutic resistance is a major problematic issue in the management of patients with breast tumor.
Files
bib-dd39facd-cd60-4bd5-9ac8-69f3a1380fff.txt
Files
(257 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:6056898dae2b13c0b52f6890eddc2e4b
|
257 Bytes | Preview Download |